Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2007
06/06/2007CN1976699A Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/06/2007CN1974568A Prepn process of aztreonam
06/06/2007CN1974562A Cycloprothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application
06/06/2007CN1974561A Cyhalothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application
06/06/2007CN1319967C 2-acylaminothiazole derivative or salt thereof
06/06/2007CN1319956C Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same
06/06/2007CN1319955C Moguisteine crystallographic form
06/05/2007US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
06/05/2007US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
06/05/2007CA2225624C Hydrazine derivatives
05/2007
05/31/2007WO2007062342A1 Heterocyclic cetp inhibitors
05/31/2007WO2007062308A2 Homo- and heterocyclic compounds suitable as cetp inhibitors
05/31/2007WO2007061661A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/31/2007WO2007061600A1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1
05/31/2007WO2007061094A1 Pharmaceutical comprising ppar agonist
05/31/2007WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007WO2007060166A1 New n-phenethylcarboxamide derivatives
05/31/2007WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
05/31/2007WO2007060121A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
05/31/2007WO2007037543A9 Biarylamide derivative
05/31/2007WO2007030618A3 Bicyclic derivatives as modulators of voltage gated ion channels
05/31/2007WO2007019251A3 Sphingosine kinase inhibitors and methods of their use
05/31/2007WO2006058700A8 Acetamide compounds as fungicides
05/31/2007WO2005108383A3 Multi-lamellar liquid crystal emulsion system
05/31/2007US20070123573 Process for the preparation of biologically active tetrahydrobenzthiazole derivative
05/31/2007US20070123523 Inhibitors of cathepsin s
05/31/2007US20070123493 Benzamide derivative
05/31/2007CA2630816A1 Pharmaceutical comprising ppar agonist
05/31/2007CA2630718A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/31/2007CA2630558A1 Catalyzed process of making c-5-substituted heterocyclic inhibitors of 11.beta.-hydroxy steroid dehydrogenase type 1
05/31/2007CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007CA2630234A1 Thrombopoietin activity modulating compounds and methods
05/31/2007CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them
05/31/2007CA2628538A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests
05/30/2007EP1789407A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
05/30/2007EP1789406A1 Thioxothiazolidinone compounds for use as pharmaceuticals
05/30/2007EP1789381A2 Inhibitors of histone deacetylase
05/30/2007EP1789040A2 Halogenated benzamide derivatives
05/30/2007EP1709014B1 Antidiabetic oxazolidinediones and thiazolidinediones
05/30/2007EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
05/30/2007EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/30/2007EP1003730B1 2-benzoyl-cyclohexane-1,3-diones
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1972897A Novel hexafluoroisopropanol derivatives
05/30/2007CN1970547A Novel febuxostat crystal form and its preparation method
05/30/2007CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
05/29/2007US7223868 Heteroaromatic glucokinase activators
05/29/2007US7223760 Substituted triazole compounds
05/29/2007US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same
05/24/2007WO2007059157A1 Bisamide inhibitors of hedgehog signaling
05/24/2007WO2007058482A1 Novel inhibitors of protein kinase
05/24/2007WO2007057139A1 Microbiocides
05/24/2007WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
05/24/2007US20070117853 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist
05/24/2007US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi
05/24/2007US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B
05/24/2007US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
05/24/2007US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
05/24/2007CA2629814A1 Bisamide inhibitors of hedgehog signaling
05/24/2007CA2628145A1 Novel dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other disorders
05/23/2007EP1787986A1 Hydroxamic acid derivative and medicine containing the same as active ingredient
05/23/2007EP1787981A1 New N-phenethylcarboxamide derivatives
05/23/2007EP1786795A2 Biphenyl thiazole carboxamides
05/23/2007EP1786794A2 Biphenyl-thiazolo-carboxamides
05/23/2007EP1786793A1 Tertiary amine salts of 2-(2-aminothiazole-4-yl)-2-(acyloxyimino)acetic acid
05/23/2007EP1786792A2 Thiazole derivatives having vap-1 inhibitory activity
05/23/2007EP1786790A1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1654213B1 Matrix metalloproteinase inhibitors
05/23/2007EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
05/23/2007EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007EP1212619B1 Substrates and screening methods for transport proteins
05/23/2007CN1969205A 滤光片及花青化合物 Filters and anthocyanin compounds
05/23/2007CN1968938A Method for preparing thiazole by aminomethylation
05/23/2007CN1317265C Cyanoacrylate derivatives and their preparation method and biological activity
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007CA2436863C Process and ester derivatives useful for preparation of cephalosporins
05/22/2007CA2382573C Substituted benzylthiazolidine-2,4-dione derivatives
05/22/2007CA2368347C Glucokinase activators
05/18/2007WO2007056496A1 Oxazole and thiazole ppar modulator
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007056366A2 Compounds and compositions as ppar modulators
05/18/2007WO2007029037A3 Class iia histone deacetylase (hdac) substrate
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007003944A3 Compounds for imaging and therapy
05/18/2007CA2626483A1 Compounds and compositions as ppar modulators
05/18/2007CA2626443A1 Oxazole and thiazole ppar modulators
05/17/2007US20070112216 Method for producing chiral mercapto amino acids
05/17/2007US20070112007 Cyclohexyl-1, 4-diamine compounds
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/16/2007EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007EP1784386A2 Histone deacetylase inhibitors